# Hypercoagulability and Thromboembolic Risk in Patients With Malignant Disease, Evaluated by Thrombelastograph (TEG®)

> **NCT00400504** · — · UNKNOWN · sponsor: **Rigshospitalet, Denmark** · enrollment: 500 (—)

## Conditions studied

- Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00400504
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-11
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 500 (—)
- **Last updated:** 2006-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00400504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00400504, "Hypercoagulability and Thromboembolic Risk in Patients With Malignant Disease, Evaluated by Thrombelastograph (TEG®)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00400504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*